Inotiv Inc. December 2023 Investor Presentation

Inotiv is a global contract research organization (CRO) offering discovery and development services for novel therapeutics through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The company has grown through 14 acquisitions and organic expansion, serving over 3,500 clients globally with revenues reaching $572.4M in FY'23.